News

New Report Highlights Risks of U.S. Drug Reimportation

New Report Highlights Risks of U.S. Drug Reimportation

While the reimportation of drugs into the U.S. from abroad is a popular topic among politicians and advocates looking for ways to reduce domestic healthcare costs, the research arm of the Healthcare Distribution Alliance has released a new report highlighting some little-discussed costs and risks associated with reimportation. Yourway is no stranger to logistical challenges and is monitoring this issue.

Back to Index
Media

Upcoming Event

ISCR conference

January 23-25, 2020
Mumbai, India
Booth #16

Media

Articles

Agility and Flexibility in a Company That Provides Both Courier and Clinical Packaging Services